Concepedia

Author

Bettina Gisslinger

Medical University of Vienna

Also Known As

B Gisslinger, B. Gisslinger, Bettina Gisslinger, Gisslinger, Bettina, Heinz Gisslinger

122

Publications

6.7K

Citations

33

H-Index

62

Concepts

All Affiliations

Medical University of ViennaUniversity of PaviaAustrian Academy of SciencesIstituti di Ricovero e Cura a Carattere ScientificoUniversity of Cologne
BG

About

Bettina Gisslinger is an author at Medical University of Vienna specializing in pathology, medicine, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

1.2K

2

Health Sciences

3

3

194

3

Public Health

3

3

264

4

Natural Sciences

1

1

43

5

Blood Transplantation

1

1

75

Bettina Gisslinger

×

46

Publications

6.1K

Citations

30

H-Index

YearCitations

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Thorsten Klampfl, Heinz Gisslinger, Ashot S. Harutyunyan,

New England Journal of Medicine

2013

1.9K

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

Ayalew Tefferi, Elisa Rumi, Guido Finazzi,

Leukemia

2013

653

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

Damla Olcaydu, Ashot S. Harutyunyan, Roland Jäger,

Nature Genetics

2009

353

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms

Jelena D. Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger,

Blood

2015

270

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Francesco Passamonti, Jürgen Thiele, François Girodon,

Blood

2012

260

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Heinz Gisslinger, Oleh Zagrijtschuk, Veronika Buxhofer‐Ausch,

Blood

2015

176

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression

Thorsten Klampfl, Ashot S. Harutyunyan, Tiina Berg,

Blood

2011

175

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

Jürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer,

Blood

2011

173

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

Georg Greiner, Bettina Sprinzl, Aleksandra Górska,

Blood

2020

169

Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans

Aleksandra E. Kornienko, Christoph Dotter, Philipp Guenzl,

Genome biology

2016

159

Page 1